Skip to main content

Table 1 Baseline characteristics

From: Percutaneous tracheostomy in patients with severe liver disease and a high incidence of refractory coagulopathy: a prospective trial

  All Coagulopathy (n = 25) Mild or no coagulopathy (n = 35) P value
Age in years 42 (16–80) 42 (16–80) 34 (16–63) 0.002a
Aetiology     
   Acute liver failure 25 (42%) 10 (40%) 15 (43%)  
   Chronic liver disease 19 (32%) 9 (36%) 10 (29%)  
   Post-transplant 9 (15%) 5 (20%) 4 (11%)  
   Other 7 (12%) 1 (4%) 6 (17%)  
Severity of disease     
   APACHE II score 19 (4–30) 20 (9–28) 19 (4–30)  
   SOFA score 13 (3–22) 14 (10–22) 12 (3–18) 0.002a
Duration of mechanical ventilation     
   Duration of CMVb 7 (0–22) 7 (0–19) 6 (1–22)  
Tracheostomy method     
   Blue Rhino® 43 17 26  
  1. Values are presented as median (and range or percentage). a p < 0.05 significant. bDuration of controlled mechanical ventilation in days prior to procedure. APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sepsis-related Organ Failure Assessment.